445 related articles for article (PubMed ID: 29103946)
1. The Relevance of Osteoclastic and Osteoblastic Activity Markers Follow-Up in Patients on Antiresorptive Osteoporosis Treatment.
Smilic TN; Novakovic TR; Markovic-Jovanovic SR; Smilic LLJ; Mitic JS; Radunovic ML
J Clin Densitom; 2018; 21(3):322-328. PubMed ID: 29103946
[TBL] [Abstract][Full Text] [Related]
2. Traditional and novel bone remodeling markers in premenopausal and postmenopausal women.
Botella S; Restituto P; Monreal I; Colina I; Calleja A; Varo N
J Clin Endocrinol Metab; 2013 Nov; 98(11):E1740-8. PubMed ID: 24001743
[TBL] [Abstract][Full Text] [Related]
3. Thalassemic osteopathy: a new marker of bone deposition.
Baldini M; Forti S; Orsatti A; Marcon A; Ulivieri FM; Airaghi L; Zanaboni L; Cappellini MD
Blood Cells Mol Dis; 2014; 52(2-3):91-4. PubMed ID: 24091145
[TBL] [Abstract][Full Text] [Related]
4. The levels of bone turnover markers in Chinese postmenopausal women: Peking Vertebral Fracture study.
Zhao J; Xia W; Nie M; Zheng X; Wang Q; Wang X; Wang W; Ning Z; Huang W; Jiang Y; Li M; Wang O; Xing X; Sun Y; Luo L; He S; Yu W; Lin Q; Pei Y; Zhang F; Han Y; Tong Y; Che Y; Shen R; Hu Y; Zhou X; Xu L
Menopause; 2011 Nov; 18(11):1237-43. PubMed ID: 21747303
[TBL] [Abstract][Full Text] [Related]
5. Biochemical markers as predictors of rates of bone loss after menopause.
Rogers A; Hannon RA; Eastell R
J Bone Miner Res; 2000 Jul; 15(7):1398-404. PubMed ID: 10893690
[TBL] [Abstract][Full Text] [Related]
6. Predictors of bone mineral density in patients receiving glucocorticoid replacement for Addison's disease.
Furman K; Gut P; Sowińska A; Ruchała M; Fichna M
Endocrine; 2024 May; 84(2):711-719. PubMed ID: 38334892
[TBL] [Abstract][Full Text] [Related]
7. Changes in bone mass and serum markers of bone metabolism after parathyroidectomy.
Thorsen K; Kristoffersson AO; Lorentzon RP
Surgery; 1997 Nov; 122(5):882-7. PubMed ID: 9369887
[TBL] [Abstract][Full Text] [Related]
8. Normal osteoclastic and osteoblastic responses to exogenous growth hormone in patients with postmenopausal spinal osteoporosis.
Kassem M; Brixen K; Blum WF; Mosekilde L; Eriksen EF
J Bone Miner Res; 1994 Sep; 9(9):1365-70. PubMed ID: 7817819
[TBL] [Abstract][Full Text] [Related]
9. Associations of Bone Mineral Density and Bone Metabolism Indices with Urine Albumin to Creatinine Ratio in Chinese Patients with Type 2 Diabetes.
Zhao X; Zhang XM; Yuan N; Yu XF; Ji LN
Exp Clin Endocrinol Diabetes; 2019 Jan; 127(1):50-55. PubMed ID: 30396213
[TBL] [Abstract][Full Text] [Related]
10. The levels of bone turnover markers 25(OH)D and PTH and their relationship with bone mineral density in postmenopausal women in a suburban district in China.
Gao C; Qiao J; Li SS; Yu WJ; He JW; Fu WZ; Zhang ZL
Osteoporos Int; 2017 Jan; 28(1):211-218. PubMed ID: 27468899
[TBL] [Abstract][Full Text] [Related]
11. [The role of biochemical markers of bone turnover in the diagnosis of osteoporosis and predicting fracture risk].
Mohamed Y; Haifa H; Datel O; Fadoua HN; Smeh BH; Mahbouba J; Saoussen Z; Bejia I; Mongi T; Mohamed FN; Naceur B
Tunis Med; 2014 May; 92(5):304-10. PubMed ID: 25504382
[TBL] [Abstract][Full Text] [Related]
12. Role of type I collagen C telopeptide, bone-specific alkaline phosphatase and osteocalcin in the assessment of bone status in postmenopausal women.
Trento LK; Pietropolli A; Ticconi C; Gravotta E; De Martino MU; Fabbri A; Piccione E
J Obstet Gynaecol Res; 2009 Feb; 35(1):152-9. PubMed ID: 19215563
[TBL] [Abstract][Full Text] [Related]
13. Effects of denosumab on bone turnover markers in postmenopausal osteoporosis.
Eastell R; Christiansen C; Grauer A; Kutilek S; Libanati C; McClung MR; Reid IR; Resch H; Siris E; Uebelhart D; Wang A; Weryha G; Cummings SR
J Bone Miner Res; 2011 Mar; 26(3):530-7. PubMed ID: 20839290
[TBL] [Abstract][Full Text] [Related]
14. Bone biomarkers in patients with chronic traumatic spinal cord injury.
Sabour H; Norouzi Javidan A; Latifi S; Larijani B; Shidfar F; Vafa MR; Heshmat R; Emami Razavi H
Spine J; 2014 Jul; 14(7):1132-8. PubMed ID: 24139865
[TBL] [Abstract][Full Text] [Related]
15. Reference intervals of β-C-terminal telopeptide of type I collagen, procollagen type I N-terminal propeptide and osteocalcin for very elderly Chinese men.
Shou Z; Jin X; Bian P; Li X; Chen J
Geriatr Gerontol Int; 2017 May; 17(5):773-778. PubMed ID: 27137883
[TBL] [Abstract][Full Text] [Related]
16. Long-term treatment of osteoporotic women with bisphosphonates does not impair the response to subsequently administered intravenous pamidronate.
Yavropoulou MP; Hamdy NA; Papapoulos SE
Osteoporos Int; 2013 Aug; 24(8):2353-7. PubMed ID: 23436076
[TBL] [Abstract][Full Text] [Related]
17. [Osteoporosis and arterial stiffness: study of 103 women with mild to moderate risk of cardiovascular disease].
Ageev FT; Barinova IV; Seredenina EM; Orlova IaA; Kuz'mina AE; Masenko VP; Kochetov AG
Kardiologiia; 2013; 53(6):51-8. PubMed ID: 23953046
[TBL] [Abstract][Full Text] [Related]
18. Correlation of plasma microRNA-21 expression and bone turnover markers in postmenopausal women.
Perksanusak T; Panyakhamlerd K; Hirankarn N; Suwan A; Vasuratna A; Taechakraichana N
Climacteric; 2018 Dec; 21(6):581-585. PubMed ID: 30232913
[TBL] [Abstract][Full Text] [Related]
19. Changes in bone mass and bone turnover following tibial shaft fracture.
Veitch SW; Findlay SC; Hamer AJ; Blumsohn A; Eastell R; Ingle BM
Osteoporos Int; 2006; 17(3):364-72. PubMed ID: 16362144
[TBL] [Abstract][Full Text] [Related]
20. Elevated Bone Turnover Markers Are Associated With Distal Radius Fractures in Premenopausal Women.
Ting BL; Walley KC; Travison TG; Rozental TD
J Hand Surg Am; 2017 Feb; 42(2):71-77. PubMed ID: 28160903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
